<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38449902</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2807-2618</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Narra J</Title><ISOAbbreviation>Narra J</ISOAbbreviation></Journal><ArticleTitle>A comparison study of headache characteristics and headache-associated quality-of-life of COVID-19 and non-COVID-19 patients.</ArticleTitle><Pagination><StartPage>e93</StartPage><MedlinePgn>e93</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e93</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.52225/narra.v2i3.93</ELocationID><Abstract><AbstractText>Headache is prevalent in coronavirus disease 2019 (COVID-19) patients. The main objective of this study was to compare the characteristics of COVID-19-associated headache to non-COVID-19 headache. The quality-of-life (QoL) and its associated determinants between COVID-19 and non-COVID-19 patients were also compared. A cross-sectional study was conducted in Banda Aceh, Indonesia. Headache and QoL were assessed using the International Classification of Headache Disorders, version 3 (ICHD-3), and the 36-item Short Form Health Survey (SF-36), respectively. Factors associated with poor QoL in COVID-19 and non-COVID-19 patients were examined using logistic regression. A total of 356 headache patients were included: 215 COVID-19 and 141 non-COVID-19 patients. Our data suggested that the headache in COVID-19 patients was bilateral; pain centered on one specific area with a pulsating or pressing sensation; pain intensity ranging from moderate to severe; and the frequency ranging from more than twice per week to every day. Non-COVID-19 headache was bilateral; pain centered on one side of the head resembling a migraine with pulsating or pressing sensation; mild to moderate pain intensity; and the frequency of one or two times per month. In COVID-19, low QoL was associated with unemployment status, having non-health-related jobs, having used painkillers to reduce the pain, having long duration of headache, having more frequency of attacks, and having headaches that were worsened by activities or light, and having additional symptom during a headache attach. In non-COVID-19 patients, poor QoL was associated with the use of painkillers, long duration of headache, and having conditions that aggravate the headache. To prevent long-term effects of headache associated with COVID-19, studies exploring the photobiology of headache are needed, along with the necessity of having standardised guideline on headache prevention.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mutiawati</LastName><ForeName>Endang</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusuma</LastName><ForeName>Hendrix Indra</ForeName><Initials>HI</Initials><AffiliationInfo><Affiliation>Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology Education, Faculty of Tarbiyah and Teacher Training, Universitas Islam Negeri Ar-Raniry, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fathima</LastName><ForeName>Raisha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syahrul</LastName><ForeName>Syahrul</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musadir</LastName><ForeName>Nasrul</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Indonesia</Country><MedlineTA>Narra J</MedlineTA><NlmUniqueID>9918625888906676</NlmUniqueID><ISSNLinking>2807-2618</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">headache</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 symptom</Keyword><Keyword MajorTopicYN="N">quality-of-life</Keyword></KeywordList><CoiStatement>All the authors declare that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>4</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38449902</ArticleId><ArticleId IdType="pmc">PMC10914131</ArticleId><ArticleId IdType="doi">10.52225/narra.v2i3.93</ArticleId><ArticleId IdType="pii">NarraJ-2-e93</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO . Coronavirus (COVID-19) Dashboard. Availave from: https://covid19.who.int/. Accessed: 15 August 2022.</Citation></Reference><Reference><Citation>Martelletti P, Bentivegna E, Spuntarelli V, et al. . Long-COVID headache. Compr Clin Med 2021;3(8):1704-1706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136258</ArticleId><ArticleId IdType="pubmed">34036244</ArticleId></ArticleIdList></Reference><Reference><Citation>Uygun O, Ertas M, Ekizoglu E, et al. . Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain 2020; 21(1):121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7552597</ArticleId><ArticleId IdType="pubmed">33050880</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza DD, Shivde S, Awatare P, et al. . Headaches associated with acute SARS-CoV-2 infection: A prospective cross-sectional study. SAGE Open Med 2021; 9:20503121211050227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511910</ArticleId><ArticleId IdType="pubmed">34659765</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhabra N, Grill MF, Singh RBH. Post-COVID Headache: A literature review. Curr Pain Headache Rep 2022; 26(11):835-842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9533267</ArticleId><ArticleId IdType="pubmed">36197571</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen MF, Skipper CP, Hullsiek KH, et al. . Symptoms of COVID-19 outpatients in the United States. Open Forum Infect Dis 2020; 7(7):ofaa271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337847</ArticleId><ArticleId IdType="pubmed">33117855</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Azorin D, Sierra A, Trigo J. , et al. Frequency and phenotype of headache in COVID-19: A study of 2194 patients. Sci Rep 2021; 11(1):14674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8290038</ArticleId><ArticleId IdType="pubmed">34282206</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai ST, Lu MK, San S, et al. . The neurologic manifestations of coronavirus disease 2019 pandemic: A systemic review. Front Neurol 2020; 11:498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7248254</ArticleId><ArticleId IdType="pubmed">32574246</ArticleId></ArticleIdList></Reference><Reference><Citation>Kacprzak A, Malczewski D, Domitrz I. Headache attributed to SARS-CoV-2 infection or COVID-19 related headache-not migraine-like problem-original research. Brain Sci 2021; 11(11):1406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615688</ArticleId><ArticleId IdType="pubmed">34827405</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker HA, Safavynia SA, Evered LA. The 'third wave': impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth 2021; 126(1):44-47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577658</ArticleId><ArticleId IdType="pubmed">33187638</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9; A, F&#xe9;lix C, Nzwalo H. Should we mind for late neurologic manifestations from novel coronavirus? Clin Neurol Neurosurg 2020; 196:106021-106021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295516</ArticleId><ArticleId IdType="pubmed">32570020</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. . Characterising long COVID: a living systematic review. BMJ Glob Health 2021; 6: 6:e005427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Bentivegna E, Cho S-J, et al. . Long COVID headache. J Headache Pain 2022; 23(1):93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson M, Nel J, Blumberg L, et al. . Long-COVID: An evolving problem with an extensive impact. S Afr Med J 2020; 111(1):10-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Navarro-Santana M, G&#xf3;mez-Mayordomo V, et al. . Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. Eur J Neurol 2021; 28(11):3820-3825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MA, Alam SS, Kundu S, et al. . Prevalence of headache in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 14,275 patients. Front Neurol 2020; 11:562634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7728918</ArticleId><ArticleId IdType="pubmed">33329305</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutiawati E, Syahrul S, Fahriani M, et al. . Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis. F1000Res 2021; 9:1316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063523</ArticleId><ArticleId IdType="pubmed">33953911</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hashel JY, Abokalawa F, Alenzi M, et al. . Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study. J Headache Pain 2021; 22(1):97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380111</ArticleId><ArticleId IdType="pubmed">34418950</ArticleId></ArticleIdList></Reference><Reference><Citation>Barulin A, Kurushina O, Drushlyakova A. Headache in patients with COVID-19. J Neurol Sci 2021;429:119291</Citation></Reference><Reference><Citation>Headache Classification Committee of the International Headache Society (IHS) . The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38(1):1-211.</Citation><ArticleIdList><ArticleId IdType="pubmed">29368949</ArticleId></ArticleIdList></Reference><Reference><Citation>Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med 2016; 4:2050312116671725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5052926</ArticleId><ArticleId IdType="pubmed">27757230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutiawati E, Kusuma HI, Fahriani M, et al. . Headache in post-COVID-19 patients: its characteristics and relationship with the quality of life. Medicina (Kaunas) 2022; 58(10).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9609032</ArticleId><ArticleId IdType="pubmed">36295660</ArticleId></ArticleIdList></Reference><Reference><Citation>Uygun &#xd6;, Erta&#x15f; M, Ekizo&#x11f;lu E, et al. . Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain 2020; 21(1):121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7552597</ArticleId><ArticleId IdType="pubmed">33050880</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H, G&#xfc;l A, Baykan B. COVID-19 is a real headache! Headache 2020; 60(7):1415-1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272895</ArticleId><ArticleId IdType="pubmed">32412101</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez J Trigo, Garc&#xed;a-Azor&#xed;n D, Planchuelo-G&#xf3;mez &#xc1;, et al. . Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients. Cephalalgia 2020; 40(13):1432-1442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645601</ArticleId><ArticleId IdType="pubmed">33146037</ArticleId></ArticleIdList></Reference><Reference><Citation>Planchuelo-G&#xf3;mez &#xc1;, Trigo J, de Luis-Garc&#xed;a R, et al. . Deep phenotyping of headache in hospitalized COVID-19 Patients via principal component analysis. Frontiers in Neurology 2020; 11: 583870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773780</ArticleId><ArticleId IdType="pubmed">33391152</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues R, Kuster G, De Castro FO, et al. . Headache features in patients with dengue virus infection. Cephalalgia 2006; 26(7):879-882.</Citation><ArticleIdList><ArticleId IdType="pubmed">16776706</ArticleId></ArticleIdList></Reference><Reference><Citation>D D.W.. A phase-by-phase review of migraine pathophysiology. Headache 2018; 58 4&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">29697154</ArticleId></ArticleIdList></Reference><Reference><Citation>Goadsby P.J., Holland P.R., Martins-Oliveira M. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 2017; 97(2):553&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5539409</ArticleId><ArticleId IdType="pubmed">28179394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayberg MR ZN, Moskowitz MA: Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol (1):46&#x2013;56 101002/cne902230105</Citation><ArticleIdList><ArticleId IdType="pubmed">6200513</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabelo LA, Alenina N, Bader B. ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease. Hypertens Res 2011; 34(2):154&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">21124322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin BE, Celikbilek A, Kocak Y, et al. . Patterns of COVID-19-related headache: A cross-sectional study. Clin Neurol Neurosurg 2022; 219:107339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9192353</ArticleId><ArticleId IdType="pubmed">35753162</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223):497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz S, Arakaki R, Iwasa T, et al. . CGRP Induces differential regulation of cytokines from satellite glial cells in trigeminal ganglia and orofacial nociception. Int J Mol Sci 2019; 20(3):711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6386987</ArticleId><ArticleId IdType="pubmed">30736422</ArticleId></ArticleIdList></Reference><Reference><Citation>Edvinsson L, Haanes KA., Warfvinge K. Does inflammation have a role in migraine? Nat Rev Neurol 2019; 15(8):483&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">31263254</ArticleId></ArticleIdList></Reference><Reference><Citation>Abboud H, Abboud FZ, Kharbouch H, et al. . COVID-19 and SARS-Cov-2 infection: pathophysiology and clinical effects on the nervous system. World Neurosurg 2020; 140:49&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255736</ArticleId><ArticleId IdType="pubmed">32474093</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio Rocha-Filho PA, Albuquerque PM, Carvalho L, et al. . Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study. J Headache Pain 2022; 23(1):2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721484</ArticleId><ArticleId IdType="pubmed">34979899</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallini A, Micieli G, Bussone G, et al. . Headache and quality of life. Headache 1995; 35(1):29-35.</Citation><ArticleIdList><ArticleId IdType="pubmed">7868331</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakar N Abu, Tanprawate S, Lambru G, et al. . Quality of life in primary headache disorders: A review. Cephalalgia 2015; 36(1):67-91.</Citation><ArticleIdList><ArticleId IdType="pubmed">25888584</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta&#x15f;kapilio&#x11f;lu &#xd6;, Karli N. Assessment of quality of life in migraine. Noro Psikiyatr Ars 2013; 50(Suppl 1):S60-s64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353081</ArticleId><ArticleId IdType="pubmed">28360587</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, et al. . Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil 2022; 101(1):48-52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>